Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
10/2003
10/16/2003US20030194413 Methods and compositions employing red rice fermentation products
10/16/2003US20030194381 Potassium phosphate and potassium carbonate, potassium fluoride, and/or potassium oxalate; calcium, strontium, silver, barium, and/or zinc salt; crystal complex
10/16/2003US20030192226 Animal decoy
10/16/2003CA2481995A1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
10/16/2003CA2481976A1 Novel thyroid receptor ligands
10/16/2003CA2481916A1 A therapeutic agent for impaired gastric accommodation
10/16/2003CA2481879A1 Hydroxamic acid derivatives
10/16/2003CA2481850A1 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
10/16/2003CA2481701A1 Benzoxazinone-derived compounds, their preparation and use as medicaments
10/16/2003CA2481463A1 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the production thereof
10/16/2003CA2481392A1 Terphenyl derivatives, preparation thereof, compositions containing same
10/16/2003CA2480818A1 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy
10/16/2003CA2480709A1 Method of improving absorption of vitamin e by a pet animal
10/16/2003CA2480446A1 Method and dietary composition for improving lipid digestibility
10/16/2003CA2480311A1 Oligomeric compounds for the modulation of hif-1alpha expression
10/16/2003CA2480084A1 Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis
10/16/2003CA2480082A1 Combination therapy for the treatment of conditions with pathogenic inflammatory components
10/16/2003CA2479777A1 6-(4-substituted-anilino)pyrimidine derivatives, method for the preparation thereof and antiviral pharmaceutical composition comprising the same
10/16/2003CA2478934A1 Process for producing oil and fat composition containing hydrophobic components of glycyrrhiza
10/16/2003CA2462708A1 Diazabicyclo alkane derivatives with nk1 antagonistic activity
10/15/2003EP1352906A1 Compositions for prevention or treatment of hepatopathy
10/15/2003EP1352897A2 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
10/15/2003EP1352896A2 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
10/15/2003EP1352895A2 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
10/15/2003EP1352659A1 Combination drugs
10/15/2003EP1352657A1 Interferon therapeutic effect-potentiating agents
10/15/2003EP1352654A1 Famotidine injections
10/15/2003EP1352653A1 Dihydrofuran cyclic tanshintones used in treating hyperammonemia and hepatic encephalopathy
10/15/2003EP1352651A2 Novel use of orexin receptor antagonists
10/15/2003EP1351975A2 C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases
10/15/2003EP1351973A1 Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy
10/15/2003EP1351966A1 Improved specificity in treatment of diseases
10/15/2003EP1351961A1 Substituted indolines as 5-ht receptor ligands
10/15/2003EP1351953A1 Quinoline derivatives as nk-3 antagonists
10/15/2003EP1351950A2 Isoindolyl and isoquinolinyl aroyl pyrrole compounds for the treatment of central nervous system disorders
10/15/2003EP1351942A1 Novel 2,3-benzodiazepine derivatives and pharmaceutical compositions containing the same as the active ingredient
10/15/2003EP1351936A1 Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression
10/15/2003EP1351935A1 Aryl piperidine derivatives as inducers of ldl-receptor expression
10/15/2003EP1351934A1 Naphthalene derivatives which bind to the ep4 receptor
10/15/2003EP1351933A1 Il-8 receptor antagonists
10/15/2003EP1351930A2 Protease inhibitors
10/15/2003EP1351929A1 Nitric oxide synthase inhibitor phosphate salt
10/15/2003EP1351924A2 Diamines as modulators of chemokine receptor activity
10/15/2003EP1351916A2 Ether compounds and compositions for cholesterol management and related uses
10/15/2003EP1351887A2 Process for the rehydration of magaldrate powder
10/15/2003EP1351693A1 Novel method and compositions for local treatment of meniere's disease, tinnitus and/or hearing loss
10/15/2003EP1351692A1 Oral formulation comprising an inhibitor compound of the ileal bile transport and an hmg co-a reductase inhibitor
10/15/2003EP1351690A2 Method of treatment of dopamine-related dysfunction through administration of a full d1 dopamine receptor agonist and with no induction of tolerance
10/15/2003EP1351683A2 Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser
10/15/2003EP1351672A1 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders
10/15/2003EP1268471B1 N-heterocyclic derivatives as nos inhibitors
10/15/2003EP1259508B1 Novel biarylcarboxamides
10/15/2003EP1246799B1 Substituted pyrrole mannich bases to combat pain and allergic reactions
10/15/2003EP1183037B1 Compositions for modulating immune response and for the treatment of inflammatory disease
10/15/2003EP0950047B1 Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them
10/15/2003EP0874558B1 Liquid oral compositions comprising a calcium compound and an acidulant
10/15/2003EP0758644B1 Sulfonyl- or sulfinyl-benzoyl-guanidine derivatives
10/15/2003CN1449448A 干细胞分化 Stem cell differentiation
10/15/2003CN1449410A Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same
10/15/2003CN1449405A Process for producing erythromycin derivative
10/15/2003CN1449404A Amine salt of lignan compound
10/15/2003CN1449396A Carbamates derived from arylalkylamines
10/15/2003CN1449390A Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
10/15/2003CN1449386A Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
10/15/2003CN1449385A Aza-bridged-bicyclic amino acid derivatives as alpha4 integrin antagonists
10/15/2003CN1449382A Polyarylcarboxamides useful as lipid lowering agents
10/15/2003CN1449377A Inhibitors of alpha4 mediated cell adhesion
10/15/2003CN1449284A 维生素c组合物 Vitamin c composition
10/15/2003CN1449281A Medicaments for treating colics
10/15/2003CN1448505A Method for production of phytolaccatoxin medicinal active substance
10/15/2003CN1448180A Prep. of capsule for promoting hepatocyte growth hormone
10/15/2003CN1448165A Health medicine capable of whetting appetite
10/15/2003CN1448163A Hepatosis treating traditional Chinese medicine formula
10/15/2003CN1448156A Garlic and lucid ganoderma extract capsule and its prepn. method
10/15/2003CN1448146A 珍珠混悬液 Pearl suspension
10/15/2003CN1448143A Prescription composition of calcium carbonate dry-mixing suspension agent
10/15/2003CN1448134A Adaptation of anethole trithione for use in prep.of medicine
10/15/2003CN1124270C Cyclopentene derivatives useful as antagonists of the motilin receptor
10/15/2003CN1124255C Inhibition of matrix metalloproteases by substituted phenethyl compounds
10/15/2003CN1124146C 'Pingweisu' capsule for treating gastric disease
10/15/2003CN1124144C Bagged kidney-invigorating Chinese herbal medicine tea and its prepn
10/15/2003CN1124138C Male silkmoth capsule and its preparing process
10/15/2003CN1124134C Naringin and naringenin as inhibitor of acyl coa-cholesterol-o-acyltransferase, ihibitor of macrophage-lipid complex accumulation on the arterial wall and preven
10/15/2003CN1124133C Hesperidin and hesperetin as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and pre
10/14/2003US6632962 Caspase inhibitors and uses thereof
10/14/2003US6632945 Treating inflammation, autoimmune diseases, destructive bone disorders, proliferative disorders, infections, neurvous system disorders, reperfusion/ischemia in stroke, cardiovascular disorders, hypoxia, edema, fever, pain
10/14/2003US6632836 To treat autoimmune disorders, cardiac arrhythmias and the like
10/14/2003US6632830 ACE-2 inhibiting compounds and methods of use thereof
10/14/2003US6632829 Thienyl, furyl and pyrrolyl-sulfonamides, useful for treating hypertension, cardiovascular disease, asthma, pulmonary hypertension, inflammatory diseases, vision defects, menstrual disorders, renal failure and other diseases
10/14/2003US6632827 Compositions of optically pure (+) norcisapride
10/14/2003US6632798 Methods for inhibiting angiogenesis
10/14/2003US6632647 Use of strains of parapoxvirus ovis against organ fibrosis
10/14/2003US6632454 Multilayer pharmaceutical product for release in the colon
10/14/2003US6632428 Hyperlipidemia, lowering both the serum cholesterol and serum triglyceride levels, culturing a Lovastatin-producing Monascus strain
10/14/2003CA2385777A1 Use of anti-tnf.alpha.antibodies and another drug
10/14/2003CA2082740C Controlled release device
10/09/2003WO2003083472A1 Method of judging risk of peiodontal disease
10/09/2003WO2003083092A1 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
10/09/2003WO2003083039A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/09/2003WO2003082898A2 Novel analogues of glucose-dependent insulinotropic polypeptide
1 ... 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 ... 1258